The global pharmaceutical filtration market size was valued at US$ 7.17 billion in 2021 and is expected to surpass around US$ 10.1 billion by 2030 with a registered CAGR of around 3.88% from 2022 to 2030.
The growth of global pharmaceutical filtration market is being driven by growing investments and funding in research and development activities. In addition, the growing acceptance of advanced treatment therapies and methods. Moreover, the rising number of market players are heavily investing in manufacturing facilities globally. For example, AbbVie Inc. funded roughly $320 million in a new small molecule and biologic active pharmaceutical ingredients manufacturing facility in Singapore in October 2016. As a result, demand for innovative products is expected to increase as biopharmaceutical firms expand.
Another factor driving the growth of global pharmaceutical filtration market is the adoption of innovative technologies by market players. In addition, the market players are investing in research and development initiatives for launching new and latest products in the global market. For example, in 2016, AstraZeneca, a renowned healthcare business, funded over $5,890 million on research and development. Furthermore, the market for pharmaceutical filtration is growing due to the rising prevalence of chronic disorders like asthma and cancer. The global pharmaceutical filtration market is also propelled by the development of advanced drugs and medications over the forecast period.
Report Scope of the Pharmaceutical Filtration Market
|Market Size by 2030||USD 10.1 Billion|
|Growth Rate from 2022 to 2030||
CAGR of 3.88%
|Largest Market||Asia Pacific|
|Fastest Growing Market||Europe|
|Forecast Period||2022 to 2030|
|Segments Covered||Product, Technique, Application, Scale of Operation, Systems, Type, Geography|
|Companies Mentioned||Graver Technologies, LLC, Meissner Filtration Products, Inc., Merck & Co., Inc., Parker-Hannifin Corporation, Sartorius Stedim Biotech S.A., 3M Company, Amazon Filters Ltd., Danaher Corporation (Pall Corporation), Eaton Corporation Plc, General Electric Company (GE Healthcare)|
Themembrane filters segment dominated the pharmaceutical filtration market in 2021. This is owing to its versatility in applications such nanofiltration, ultrafiltration, cross-flow filtration, and microfiltration. As membrane filters are utilized in so many applications, the market share is predicted to grow significantly during the projection period.
The single use systems segment is fastest growing segment over the forecast period. These systems offer a number of benefits, including decreased contamination risk, reduced operation time, and ease of use. As a result, single use systems are projected to become more popular in upcoming years. They are also small in size, so they take up less room in factories.
The microfiltration segment dominated the pharmaceutical filtration market in 2021. Microfiltration is a technology for clarifying, separating, and purifying proteins that is widely utilized. The feed stream flows parallel to the membrane in tangential flow microfiltration, which prevents plant pollutants from clogging the membrane. The lateral flow microfiltration can thus be utilized to simplify difficult to filter results like crude plant extracts, which induce membrane fouling quickly when filtered with traditional dead-end procedures.
The ultrafiltration segment is expected to witness significant growth over the forecast period. Due to its various applications in protein purification, antibody processing, and vaccines, the ultrafiltration category is expected to increase at a profitable rate. The market players are laser focused on meeting the precise requirements of healthcare filtration processes. Merck Millipore, for example, introduced the Mobius FlexReady Solution in January 2013, which is a fully automated, ready to use solution that is perfect for contract manufacturing organizations with quickly changing demands.
The final product processing segment dominated the pharmaceutical filtration market in 2021. Due to its widespread use in active pharmaceutical component processing, vaccine processing, protein purification, virus clearance, and antibody processing, the final product processing segment is growing at a rapid pace over the forecast period.
The cell separation segment is projected to hit significant growth from 2022 to 2030. The synthesis of monoclonal antibodies, therapeutic proteins, and vaccines all need cell separation. For cell separation applications, depth filtration and microfiltration are widely utilized. These items are expected to be widely used in emerging and established nations. The leading healthcare firms, well developed healthcare infrastructure, and modern goods all support the growth of the segment.
Scale of Operation Insights
The manufacturing scale segment dominated the pharmaceutical filtration market in 2021. Due to increased production of generic medications, biopharmaceuticals, and vaccines utilized for treatment of numerous disorders, the manufacturing scale of operation retained the biggest market share.
The research and development scale segment is predicted to hit notable growth over the forecast period. Due to increased funding and investment in research and development for new technology and product development, the research and development scale segment is expected to grow at a significant rate throughout the forecast period. For example, member organizations of the Pharmaceutical Research and Manufacturers of America spent roughly $58.8 billion on research and development in 2015.
Asia-Pacific dominated the pharmaceutical filtration market in 2021. China and India dominated the pharmaceutical filtration market in Asia-Pacific region. The pharmaceutical filtration market in Asia-Pacific region is being driven by existence of biopharmaceutical and pharmaceutical firms. In addition, growing fundings and investments by contract research organizations and contract manufacturing organizations is also driving the growth of Asia-Pacific pharmaceutical filtration market. Moreover, the favorable government regulations for development of biologics and drugs and medications are supporting the expansion of global pharmaceutical filtration market.
Europe is expected to develop at the fastest rate during the forecast period. The UK dominates the pharmaceutical filtration market in Europe region. The growth of pharmaceutical filtration market in Europe region is attributed to the adoption of innovative and latest technologies. In addition, the surge in demand for biopharmaceuticals as well as expansion of healthcare sector is also propelling the growth of Europe pharmaceutical filtration market. Furthermore, strong distribution network in the region is contributing to the growth and development of pharmaceutical filtration market in the region.
Some of the prominent players in the global pharmaceutical filtration market include:
Segments Covered in the Report
By Scale of Operation
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client